We are live on ! Find out more
RVPH

REVIVA PHARMA HLDGS INC
RVPH

Delisted

RVPH was delisted on the 13th of May, 2026.

Back to rankings

5 hedge funds and large institutions have $3.67K invested in REVIVA PHARMA HLDGS INC in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

45.38% less ownership

Funds ownership: 45.38% → 0% (-45%)

86% less funds holding

Funds holding: 35 → 5 (-30)

91% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 33

100% less capital invested

Capital invested by funds: $2.13M → $3.67K (-$2.13M)

Holders
5
Holders Change
-30
Holders Change %
-85.71%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
33
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MGI
Miller Global Investments
Texas
+$1
2
MWM
Mosley Wealth Management
California
+$1

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$579K
2
HCM
Highbridge Capital Management
New York
-$556K
3
AC
Armistice Capital
New York
-$432K
4
GCP
GSA Capital Partners
United Kingdom
-$191K
5
Vanguard Capital Management
Vanguard Capital Management
Pennsylvania
-$85.8K

RVPH Hedge Fund Activity: Q2 2026 in Review

5 of the 8,340 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q2 2026, worth a combined $3.67K — down 100% from $2.13M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of RVPH and 3 opened new positions — a net loss of 30 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Miller Global Investments, opening a new position worth an estimated $1. The largest seller was Millennium Management, exiting entirely with an estimated $579K sold.

  • 5 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q2 2026, down from 35 in Q1 2026.
  • Funds reported $3.67K of REVIVA PHARMA HLDGS INC stock for Q2 2026, down 100% quarter-over-quarter.
  • 3 funds opened new REVIVA PHARMA HLDGS INC positions in Q2 2026 and 33 closed out, a net change of -30 holders.
  • The largest REVIVA PHARMA HLDGS INC buyer in Q2 2026 was Miller Global Investments, an estimated $1 added.
  • The largest REVIVA PHARMA HLDGS INC seller in Q2 2026 was Millennium Management, an estimated $579K sold.

Based on aggregated 13F filings for Q2 2026.